About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNPhase 2

R Retreatment in 1st Relapsed DLBCL

A Multicenter, Open Label, Phase II Trial of Rituximab in Combination With ICE as Salvage Therapy in the Relapsed DLBCL Patients After 1st Line Induction Treatment of 6-8 Cycles of RCHOP-LIKE Chemo

NCT00980304•Shanghai Jiao Tong University School of Medicine

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Lymphomas

Interventions

Rituximab

Key Dates

Last Updated

September 21, 2009

Related Studies

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

NCT00006518

HIVKaposi's Sarcoma+3 more

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

NCT04417803

Enrolling By InvitationPhase 1

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT04488354

Relapsed/Refractory B-cell LymphomasDiffuse Large B-Cell Lymphoma (DLBCL)+10 more

Active Not RecruitingPhase 1

A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas

NCT05290597

Solid Malignancies or Lymphomas

Active Not RecruitingPhase 1/2

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

NCT02223208

Peripheral T-cell Lymphomas (PTCL)PTCL-NOS+3 more

Active Not RecruitingPhase 3

Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas

NCT00877214

Follicular LymphomasImmunocytomas+4 more

View all related studies

Sponsors

Lead Sponsor

Shanghai Jiao Tong University School of Medicine

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 21, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions